Skip to main content
NCBI home page
Frontiers in Physiology logoLink to Frontiers in Physiology
. 2019 Nov 28;10:1463. doi: 10.3389/fphys.2019.01463

Neuromuscular Electrical Stimulation: A New Therapeutic Option for Chronic Diseases Based on Contraction-Induced Myokine Secretion

Fabian Sanchis-Gomar 1,*,†, Sergio Lopez-Lopez 2,†, Carlos Romero-Morales 2, Nicola Maffulli 3,4,5, Giuseppe Lippi 6, Helios Pareja-Galeano 2
PMCID: PMC6894042  PMID: 31849710

Abstract

Myokines are peptides known to modulate brain neuroplasticity, adipocyte metabolism, bone mineralization, endothelium repair and cell growth arrest in colon and breast cancer, among other processes. Repeated skeletal muscle contraction induces the production and secretion of myokines, which have a wide range of functions in different tissues and organs. This new role of skeletal muscle as a secretory organ means skeletal muscle contraction could be a key player in the prevention and/or management of chronic disease. However, some individuals are not capable of optimal physical exercise in terms of adequate duration, intensity or muscles involved, and therefore they may be virtually deprived of at least some of the physiological benefits induced by exercise. Neuromuscular electrical stimulation (NMES) is emerging as an effective physical exercise substitute for myokine induction. NMES is safe and efficient and has been shown to improve muscle strength, functional capacity, and quality of life. This alternative exercise modality elicits hypertrophy and neuromuscular adaptations of skeletal muscles. NMES stimulates circulating myokine secretion, promoting a cascade of endocrine, paracrine, and autocrine effects. We review the current evidence supporting NMES as an effective physical exercise substitute for inducing myokine production and its potential applications in health and disease.

Keywords: electrotherapy, cytokines, transcutaneous electrical nerve stimulation, physical exercise, skeletal muscle contraction

Introduction

Functions classically attributed to skeletal muscle are movement and maintenance of posture, protection of vital organs, stimulation of blood and lymphatic circulation, and activation of metabolic pathways as the consequence of the large amount of energy consumed. More recently, this perspective has broadened, as contracting skeletal muscles have been shown to release molecules responsible for signal transmission to other tissues (Hawley et al., 2014). These molecules were referred to as “the work stimulus,” “the work factor” or “the exercise factor” (Pedersen et al., 2003). It was originally hypothesized that this exercise factor could be potassium ions, lactic acid, adenosine, interleukin (IL)-6 or other metabolites, until Pedersen et al. (2003) suggested in 2003 that cytokines – produced and released by skeletal muscles contraction and exerting their effects on other organs – should be named “myokines.”

Myokines are recognized as potential candidates to manage metabolic diseases through their capacity to modulate fuel oxidation, hypertrophy, angiogenesis, inflammatory processes, and extracellular matrix regulation (Leal et al., 2018; Piccirillo, 2019). Myokines may also influence the onset and the course of other diseases through their endocrine functions, as they interplay with body weight regulation, inflammation, insulin sensitivity, tumor growth, and cognitive function (So et al., 2014; Carson, 2017; Hoffmann and Weigert, 2017). Thus, myokines may exert beneficial effects on metabolic syndrome-related disorders such as obesity, insulin resistance and type-2 diabetes, dyslipidemia; cardiovascular diseases such as hypertension and coronary heart disease; breast and colon cancer; and neuropsychiatric diseases such as Alzheimer’s, Parkinson’s and depression (Sanchis-Gomar and Perez-Quilis, 2014; Sanchis-Gomar et al., 2014; Pareja-Galeano et al., 2015).

Myostatin was the first myokine identified in 2008 (Allen et al., 2008), and IL-6 was the first myokine found to be secreted into the bloodstream in response to muscle contraction (Pedersen and Febbraio, 2008). Since then, several hundred myokines have been described, including cytokines, small proteins (∼ 5–20 kDa) and proteoglycan peptides produced and released by contracting muscle cells via secretion of proteins that signal between muscle and the rest of the body (Pedersen et al., 2007; Catoire et al., 2014). Thus, these peptidic molecules are expressed, produced, and released by muscle fibers which thus exert autocrine, paracrine, and/or endocrine effects (Pedersen et al., 2003). The autocrine, paracrine and/or endocrine (systemic) actions of myokines occur at picomolar concentrations (Pedersen and Febbraio, 2012; Pedersen, 2013). The autocrine and paracrine effects of myokines are mainly involved in the regulation of muscle physiology, muscle growth or lipid metabolism. However, myokine receptors have been identified in different tissues and organs, including the muscle itself, adipose tissue, liver, pancreas, bone, brain, heart, vessels, and immune cells, thereby modulating a myriad of functions (Pedersen et al., 2007; Lee and Jun, 2019).

Plasma levels of most myokines depend on the amount of contracted muscle mass and are hence strongly related to the amount of muscle mass exercised (Pedersen and Febbraio, 2008; Hody et al., 2019). For instance, IL-6 production is sensitive to exercise intensity (Ostrowski et al., 2000), an indirect measure of the muscle mass involved in contractile activity (Pedersen and Febbraio, 2008). Contracting skeletal muscle is an important source of plasma IL-6 (Steensberg et al., 2000; Fischer et al., 2004), and exercise involving a limited muscle mass (e.g., upper limb muscle) may be insufficient to significantly increase plasma IL-6 levels (Nosaka and Clarkson, 1996; Hirose et al., 2004; Bergfors et al., 2005; Pedersen and Febbraio, 2008). The sharpest increase in plasma IL-6 is typically observed in running, which involves several large muscle groups (Fischer, 2006; Pedersen and Fischer, 2007). On the other hand, although IL-8 mRNA increases up to 10-fold in response to exercise and up to twofolds with a pharmacological cocktail (palmitate, forskolin, and ionomycin) to mimicking exercise-stimulated contractions in vitro (Covington et al., 2016), circulating IL-8 increases only transiently after exhaustive exercise, suggesting that this myokine acts only locally in an autocrine/paracrine fashion (Nielsen and Pedersen, 2007). In this regard, neuromuscular stimulation of cultured human primary skeletal muscle cells (hSkMCs) increases IL-8 secretion by muscle cells (Scheler et al., 2013). The production of the myokine brain-derived neurotrophic factor (BDNF) is stimulated by some types of physical exercise. Acute aerobic exercise leads to increased BDNF plasma levels in an intensity-dependent manner, whereas acute strength exercise does not elicit this effect (Knaepen et al., 2010; Huang et al., 2014). Thus, rest periods between efforts, relative intensity and a limited amount of muscle mass mobilized and contracted simultaneously during strength exercise could limit the production of this and other myokines (Table 1).

TABLE 1.

List of myokines potentially induced by muscle contraction and regular exercise (So et al., 2014; Schnyder and Handschin, 2015; Lightfoot and Cooper, 2016; Garneau and Aguer, 2019).

  • •

    Angiopoietin-like 4 (ANGPTL4)

  • •

    Apelin

  • •

    β-aminoisobutyric acid (BAIBA)

  • •

    Brain-derived neurotrophic factor (BDNF)

  • •

    Chemokine ligand and chemokine (C-X-C motif) ligand family

  • •

    Decorin

  • •

    Fibroblast growth factor 21 (FGF21)

  • •

    Interleukin-6 (IL-6)

  • •

    IL-8

  • •

    IL-10

  • •

    IL-13

  • •

    IL-15

  • •

    IL-18

  • •

    Irisin (FNDC5)

  • •

    Musclin

  • •

    Myonectin - C1q tumor necrosis factor a-related protein isoform 5 (C1QTNF5)

  • •

    Myostatin

  • •

    Leukemia inhibitory factor (LIF)

  • •

    Secreted protein acidic rich in cysteine (SPARC)

  • •

    Tumor necrosis factor-alpha (TNF-α)

Open in a new tab

Active skeletal fibers produce and release several myokines that act as hormones (Carson, 2017). These myokines released into the bloodstream exert well defined specific endocrine effects in different organs. This endocrine function of skeletal muscle may underlie numerous health benefits such as maintaining adequate body weight, reducing low-grade inflammation typical of chronic diseases, improving insulin sensitivity, protecting from tumor growth, and improving cognitive function. Therefore, physical exercise in which large muscle groups are mobilized at sufficient intensity and duration may produce benefits from a modulation of circulating myokines (He et al., 2018). Exercise also increases circulating small vesicles and exosomes as well as extracellular vesicles-packaged proteins involved in several biological functions (Whitham et al., 2018). Importantly, extracellular exosomes and extracellular matrix proteins might also be classified as myokines, particularly the extracellular matrix protein tenascin C, which is produced after electrical stimulation (Crameri et al., 2007) and affect muscle healing and regeneration (Fluck et al., 2008). However, the physical and metabolic limitations of some individuals will prevent them from undertaking physical exercise of sufficient intensity or duration to trigger such a myokine response.

Neuromuscular electrical stimulation (NMES) is based on applying in the transcutaneous electrical currents to a group of muscles, stimulating it to contract (Veldman et al., 2016). This method is usually employed as a passive “substitute” of dynamic training and acts as an “exercise emulator.” In fact, NMES can activate PGC-1α (the master regulator of mitochondrial biogenesis activated by endurance exercise) as well as the target of rapamycin (mTOR), which in turn activates insulin and IGF-1 receptors (Atherton et al., 2005). Accordingly, this strategy could be particularly useful in patients with paraplegia, tetraplegia, obesity and limited mobility, frail elderly, or any person needing prolonged bed rest.

This review describes the most relevant in vivo research findings linking NMES and endocrine myokine expression, revealing NMES as an ergo-mimetic agent, and discusses how this method of stimulating the production of plasma myokines can exert a beneficial effect on the pathophysiology of several conditions in patients with limited mobility. We have particularly focused on myokines for which sufficient scientific evidence is currently available.

Myokine Production Throughout Neuromuscular Electrical Stimulation: a Review of In Vivo Evidence

Neuromuscular electrical stimulation may act as an efficient protector of muscle competence when subjects are unable or unwilling to engage in resistance or aerobic training programs. In accordance with this hypothesis, superimposed muscle contraction produced by electrical stimulators was found to enhance functional capacity in heart failure (HF) patients tested using the 6-min walk test (Nuhr et al., 2004; Karavidas et al., 2006). Similar results emerged from a meta-analysis of functional electrical stimulation in patients with chronic HF (Sbruzzi et al., 2010). Thus, NMES improved functional capacity (measured as VO2peak) in HF patients to a similar extent as conventional aerobic training. The greatest improvements in the NMES group were detected in patients with a lower exercise capacity (Deley et al., 2008). A Cochrane systematic review (Jones et al., 2016) considered NMES a valid therapeutic intervention to improve muscle weakness in adults with conditions such as chronic obstructive pulmonary disease (COPD), chronic respiratory disease, chronic HF, or thoracic cancer. Likewise, NMES could be useful during recovery from injury (Caggiano et al., 1994; Wall et al., 2015), since it increases antioxidant capacity and decreases redox imbalance caused by disuse (Gondin et al., 2011a, b; Pellegrino et al., 2011).

Interleukins

NMES behaves as a powerful stimulus to skeletal muscle with systemic consequences when undertaking considered at low to moderate workload. Compared to groups in which the only intervention was active cycling or passively applied NMES, cycling plus NMES produced the greatest increases in plasma IL-6 levels immediately and 30 and 60 min after the intervention, showing a significant interaction effect (intervention∗time) (partial η2 = 0.55; power = 0.99) (all p < 0.001) (Wahl et al., 2015).

The duration of exercise seems to be the most critical factor regulating the amplitude of the systemic IL-6 response. Since the intervention time was exactly the same for the three groups, these results may arise from the larger amount of muscle mass engaged in the intervention combining NMES and active cycling (Fischer, 2006).

Increased peripheral blood levels of IL-6 were measured after a single 30-min NMES session in healthy participants receiving bilateral lower extremity muscle stimulation in the quadriceps, tibialis anterior and gastrocnemius. This intervention produced a significant increase in peak IL-6 from the mean pre-NMES value [0.65 (0.89) to 1.04 (0.89) pg ml–1, P = 0.001], and a significant decrease in interleukin-10 (IL-10) [0.08 (0.07) to 0.02 (0.02) pg ml–1, P = 0.041] and TNF-α [2.42 (0.54) to 2.16 (0.59) pg ml–1, P = 0021]. Significantly higher mean values of IL-6 were also observed after NMES throughout the full 120-min period (Truong et al., 2017).

Although the magnitude of change was not impressive, these results are in line with similar responses to exercise observed in healthy adults (Greiwe et al., 2001; Steensberg et al., 2002). Truong et al. (2017) demonstrated a clear relationship between exercise-induced release of IL-6 and TNF-α, thus supporting its putative anti-inflammatory role. Specifically, IL-6 seems to exert its anti-inflammatory actions during low to moderate exercise, through induction of IL-1ra transcription, which in turn inhibits the pro-inflammatory cytokine IL-1. Moreover, IL-6 increases the production of IL-10, which inhibits lipoprotein saccharide-stimulated production of the pro-inflammatory cytokines TNF-α, IL-1α, and IL-1β (Steensberg et al., 2003; Fischer, 2006).

Chronic conditions such as COPD may lead to a pro-inflammatory state. In these situations, IL-6 may be increased in the presence of increased TNF-α expression. Akar et al. (2017) studied COPD exacerbation during intubation in hospital, and found significantly reduced plasma IL-6 levels after a rehabilitation program based on NMES and active mobilization [5.70 (1.70–13.70) – 1.20 (0.50–2.70) (P = 0.015)], and on NMES alone [3.35 (0.70–14.18) – 1.20 (0.50–6.70) (P = 0.068)]. The intervention group only undergoing active mobilization showed increased IL-6 levels without significant differences (Akar et al., 2017). Similarly decreased levels of IL-8 were found in a NMES and active mobilization group [13.64 (1.47–23.70) – 2.35 (0.80–17.63) (P = 0.017)], and a NMES alone group [6.13 (2.35–25.00) – 3.92 (0.80–17.63) (P = 0.017)]. This time, the active mobilization intervention group showed no significant differences in IL-8. Although no significant difference was reported, NMES and active mobilization, as well as NMES alone, were effective in increasing IL-10, whereas the active mobilization alone group showed reduced IL-10 values. This downregulation of IL-6 and IL-8, and upregulation of IL-10, could be consequent to a reduced proinflammatory state mediated by muscle contraction.

Brain-Derived Neurotrophic Factor

Miyamoto et al. (2018) carried out several studies in healthy subjects and those with type 2 diabetes mellitus. These authors reported significantly improved plasma BDNF concentrations after an 8-week period of NMES training and after a single bout of NMES, respectively. In this study, a single 30 min bout of NMES significantly increased plasma BDNF levels (pre-NMES: 150.5 ± 126.7 vs. post-NMES: 250.5 ± 131.1 pg mL–1; p = 0.017); this effect was similar to that observed in subjects completing a 30-min cycling ergometer exercise test at 60% VO2peak (post-NMES: 250.5 ± 131.1 vs. post-exercise: 268.6 ± 123.8 pg ⋅ mL–1; p = 0.908). However, this acute response was not associated with an improvement in cognitive function (Miyamoto et al., 2018). The 8-week protocol of NMES training in subjects with type 2 diabetes was able to induce a significant increase in plasma BDNF (pre-NMES: 117.0 ± 40.4 vs. post-NMES 245.5 ± 51.2 pg/ml; p = 0.026) compared to participants allocated to the control group and who showed a decline in plasma BDNF during the 8-week period without NMES. The NMES intervention also induced a greater reduction in the body fat percentage and fasting glucose concentrations than in the control group (Miyamoto et al., 2018).

Kimura et al. (2019) compared voluntary exercise and NMES-induced muscle contraction with the same integrated force measured using electro-myographic technology, and observed that the increase in serum BDNF in the NMES group was higher than that in the voluntary exercise group (18625.6 ± 4173.5 pg/ml, p = 0.003 vs. 15103.0 ± 4177.9 pg/ml, p = 0.004). NMES could therefore be even more effective than active exercise using the same integrated force to increase serum BDNF.

Several animal experiments have also examined the relationship between BDNF and exercise. In 2017, Dalise et al. (2017) obtained surprising results in Sprague-Dawley rats. These authors compared serum myokines such as vascular endothelial growth factor-A (VEGF-A), insulin-like growth factor-1 (IGF-1), Klotho (i.e., an anti-aging single-pass membrane protein), and BDNF produced in response to different intensities (low, medium, or high) of active exercise and analogous NMES interventions. NMES did not modify IGF-1 levels yet led to a modest increase in plasma Klotho concentrations in the low- and high intensity interventions. Notably, after a medium-intensity session of NMES, serum BDNF underwent a dramatic eightfold increase (p = 0.01).

Maekawa et al. (2018) found that 50 repeated maximal electrically evoked-isometric contractions in unconscious rats were effective at increasing BDNF protein expression and activate its hippocampus receptor. These findings could provide reliable evidence of an alternative means of communication between muscle and different organs, additional to endocrine interactions.

Myostatin

Myostatin is an inverse modulator of muscle mass in animals and humans (McPherron and Lee, 1997; Schuelke et al., 2004; Mosher et al., 2007), inhibiting mTOR signaling (Rodriguez et al., 2011). Wall et al. (2012) showed that the expression of myostatin mRNA declined significantly after 60 min of NMES in the lower limbs, coinciding with a significant increase in MyoD mRNA expression. These results are consistent with an anabolic stimulus following a bout of resistance exercise. Dirks et al. (2014) reported that the expression of myostatin mRNA was lower after NMES compared to baseline or a control group not receiving electrical stimulation. The expression of MyoD mRNA was also increased after NMES compared to values recorded at baseline and in the non-NMES group.

Gh and Igf-1 Signaling

In an experimental study in rats subjected to sciatic neurectomy to reproduce adverse effects such as disuse amyotrophy and cortical bone loss (Feng et al., 2016), 30-min NMES sessions 5 days per week for 9 weeks downregulated mRNA expression levels of myostatin and upregulated those of mechano-growth factor (MGF) and insulin-like growth factor 1 (IGF-1).

In a treadmill study in Sprague-Dawley rats, resistance training (based on superimposed NMES-induced isometric contraction) led to increased and maintained IGF-1 and GLUT-4 translocation compared to aerobic exercise, suggesting a potential role of NMES resistance training as a regulator of glucose metabolism (Kido et al., 2016).

The growth hormone (GH) response to exercise is a driving force of anabolic protein synthesis linked to strength and muscle mass enhancement. NMES is a valid and efficient tool to stimulate a hormone response in healthy subjects (Aldayel et al., 2010; Wahl et al., 2014). Collectively, evidence so far suggests that NMES mediates a protective effect on muscular structural integrity and functional capacity via autocrine and paracrine mechanisms.

Dose-Effect Relationship Between Contraction Intensity and Myokines

Unfortunately, no information exists on a minimal contraction and/or number of sessions needed to stimulate myokines’ secretion. However, although at present there are no precise data about the dose-response relationship between NMES-induced contraction intensity and myokines secretion, higher intensities of muscle contraction provoked by NMES improved muscle function in patients after an anterior cruciate ligament reconstruction (Snyder-Mackler et al., 1994). There is also a linear dose-response relationship between the increase in energy expenditure and the intensity of NMES in healthy subjects (Hsu et al., 2011) as well as with muscle function in patients with rheumatoid arthritis (Almeida et al., 2018). Likewise, a linear dose-response relationship was observed between NMES intensity and quadriceps strength and voluntary activation in subjects who received NMES after total knee arthroplasty, although there was no evidence of an association with muscle cross-sectional area (Marmon and Snyder-Mackler, 2011). Therefore, it is likely that there is a dose-effect relationship between NMES intensity and other variables, but additional investigations are still needed to elucidate the dose-effect relationship between NMES intensity-frequency-duration-muscle/s and myokines’ secretion.

Potential Drawbacks and Limitations of Using Nmes

NMES-provoked muscle damage characterized by histological alterations in muscular and connective tissue, creatine kinase (CK) activity increases, declines in muscle strength, and delayed onset muscle soreness has been recently reported (Nosaka et al., 2011). Several cases of rhabdomyolysis induced by NMES have been reported (Guarascio et al., 2004; Kastner et al., 2015; Johannsen and Krogh, 2019). NMES might increase myostatin (also named GDF-8; growth/differentiation factor 8), an inhibitor of skeletal muscle growth, and GDF-15 (growth differentiation factor 15), suggesting thus that excessive NMES could damage muscles (Bloch et al., 2014). Nevertheless, it seems that pre-conditioning muscles by isometric contractions or submaximal eccentric might attenuate NMES-provoked muscle damage (Nosaka et al., 2011).

On the other hand, a rehabilitation program including NMES must be accompanied by functional task to guarantee the eventual success of the intervention (Azman and Azman, 2017). Although there is controversy regarding the additional benefits of “superimposed” NMES in trained subjects vs. voluntary exercise alone, the former could be effective in untrained subjects or in patients who cannot mobilize appropriately (Paillard et al., 2005). Superimposed NMES seems more effective than voluntary exercise alone for the prevention of muscle atrophy, maintenance of muscle oxidative capacity and prevention of strength loss, and to recover knee function and gait kinematics after ligament surgery (Eriksson and Haggmark, 1979; Snyder-Mackler et al., 1991). A large muscle mass and a higher strain to skeletal muscles than normal are needed to increase the secretion of certain myokines (Wahl et al., 2015): this is the reason why superimposed NMES might be more effective to induce a higher local muscle stimulus for myokine secretion. Finally, voluntary exercise is at least as beneficial as superimposed NMES, although the latter could produce additional benefits in weaker muscles (Hartsell, 1986).

Most Commonly Neuromuscular Electrical Stimulation Protocols Used in Humans to Evaluate Circulating Myokine’s Secretion

Table 2 summarizes the most commonly NMES protocols used in human investigations. In general, NMES sessions last ∼20 to 60 min, with a stimulation frequency between 4 and 2000 Hz, pulse (biphasic rectangular pulses) duration of 50–1000 μs, with the highest tolerable intensity to maximize force production, performed every day in patients with activation neural deficits, and alternate days to produce hypertrophy in the affected muscle when the neural deficits have improved (Maffiuletti et al., 2018).

TABLE 2.

Summary of the different NMES protocols most commonly used to evaluate circulating myokine’s secretion in humans.

Study Type Frequency Pulse width Intensity Time Total number of sessions Stimulated zone Others
Dirks et al., 2014 Biphasic symmetrical rectangular-wave pulses Warm-up:
5Hz Stimulation period:
100Hz Cooling down phase: 5Hz		 Warm-up: 250 μs Stimulation period: 400 μs Cooling down phase: 250 μs Subjects set the intensity of the stimulation to a level at which full contractions of m quadriceps femoris were visible and palpable Warm-up: 5′ Stimulation period: 30’ Cooling down phase: 5′ 10 sessions (2 sessions per day/5-day period) Self-adhesive electrodes placed on the distal part at the m. rectus femoris and the m. vastus lateralis Volunteers were subjected to 5 days of one-legged knee immobilization
Wahl et al., 2015 Bipolar rectangular pulse continuously applied 60 Hz 400 μs Progressively increased at maximum tolerated 60′ One unique session Circular electrodes around the thigh and the calf and laminar electrodes in the gluteal zone The electrical stimulation was continuous and independent from the cycling
Akar et al., 2017 Symmetrical biphasic squared waveform, pulsed (ramp- up 1.5 s, 6 s duration contraction and 0.75 ramp-down; the rest time was not reported and the duty-cycle rest was unknown) 50 Hz Not reported Until visible contraction was obtained, 20-25 mA (depending on patient tolerance). Not reported 20 sessions (5 days per week, 4 weeks). bilateral upper extremity (deltoid) and bilateral lower extremity (quadriceps). Volitional contraction was not allowed for the patients
Dalise et al., 2017 Interference wave at an amplitude-modulated frequency of 20 Hz, on-off ratio 4.5:4.5 s (ramp-up 1 s and ramp-down 0.5 s) 2000 Hz 50 μs Progressively increase to the highest tolerated intensity during the experiment 20′ One unique session Bilateral lower limbs (quadriceps) were stimulated alternately –
Truong et al., 2017 Pulsed asymmetrical biphasic waveform (2 s ramp-up, 5 s duration contraction and <1 s ramp-down, 8/18 duty-cycle) 50 Hz 400 μs for quadriceps and 250 μs for tiabialis anterior and gastrocnemius Until visible contractions were obtained 30′ One unique session Quadriceps, tibialis anterior and gastrocnemius Electrical stimulation of the tibialis anterior and gastrocnemius alternated to stimulate physiologic volitional contraction in order to prevent discomfort
Maekawa et al., 2018 Pulsed rectangular waveform (3 s stimulation time and 7 s rest period Duty-cycle: 3/10) 100 Hz 1000 μs 3 to 5 V 10 contractions per set, 5 sets with an interval of 3’ One unique session Triceps surae muscle. –
Miyamoto et al., 2018 Pulsed rectangular monophasic wave form 4 Hz 250 μs Progressively increased until maximum tolerated 30’ (single bout of NMES) and 40’ for the 8 weeks protocol One unique session and 5 days per week, for 8 weeks (40 sessions), respectively Circular electrodes were used around the thigh and the calf and laminar electrodes were placed in the gluteal zone –
Kimura et al., 2019 Interference wave at an amplitude-modulated frequency of 20 Hz, on-off ratio 4.5:4.5 s (ramp-up 1 s and ramp-down 0.5 s) 2000 Hz 0.05 ms Progressively increase to the highest tolerated intensity during the experiment 20’ One unique session Bilateral lower limbs (quadriceps) were stimulated alternately –
Open in a new tab

Conclusion

The available data show that NMES is safe and efficient to improve muscle strength, functional capacity and quality of life. Evidence mounts that NMES stimulates the secretion of circulating myokines with clinically relevant endocrine, paracrine and autocrine consequences (Figure 1). Accordingly, NMES may have many potential effects and applications in health and disease. Although further data are needed, including measurements of other central myokines (Table 1), current evidence suggests that NMES may be a useful physical exercise substitute for myokine modulation eliciting skeletal-muscle hypertrophy and neuromuscular adaptations.

FIGURE 1.

FIGURE 1

Open in a new tab

NMES-induced myokine production and its effects on health. BDNF, brain-derived neurotrophic factor; GH, growth hormone; IGF-1, insulin-like growth factor 1; MGF, mechano-growth factor.

Limitations

This review was not planned to be a comprehensive, systematic, and/or cumulative review of existing evidence regarding NMES pros and cons, but a narrative review aiming to give a broad overview on NMES clinical use and address whether there is enough scientifically valid evidence to recommend NMES as an effective physical exercise substitute or complement to induce myokine production, and delineate the potential applications of NMES in health and disease. Therefore, there was not a predefined protocol-based search method of the bibliography which might involve subjective selection bias. Unfortunately, there are not many scientific studies that specifically evaluate the effects of NMES on circulating myokine levels. For that reason, we have limited this review to certain myokines for which sufficient scientific evidence is currently available. Therefore, additional studies would be needed for particularly assessing the potential role of NMES in regulating the expression of a wider variety of myokines.

Author Contributions

FS-G conceived and coordinated the writing of the manuscript. FS-G, SL-L, CR-M, NM, GL, and HP-G contributed to the writing of the manuscript. HP-G prepared the figure.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding

FS-G was supported by a postdoctoral contract granted by “Subprograma Atracció de Talent – Contractes Postdoctorals de la Universitat de València.” HP-G was supported by the Research Projects with internal funding by Universidad Europea (#2019/UEM01 and #2018/UEM50 asisa-UEM).

References

  1. Akar O., Gunay E., Sarinc Ulasli S., Ulasli A. M., Kacar E., Sariaydin M., et al. (2017). Efficacy of neuromuscular electrical stimulation in patients with COPD followed in intensive care unit. Clin. Respir. J. 11 743–750. 10.1111/crj.12411 [DOI] [PubMed] [Google Scholar]
  2. Aldayel A., Jubeau M., Mcguigan M., Nosaka K. (2010). Comparison between alternating and pulsed current electrical muscle stimulation for muscle and systemic acute responses. J. Appl. Physiol. 109 735–744. 10.1152/japplphysiol.00189.2010 [DOI] [PubMed] [Google Scholar]
  3. Allen D. L., Cleary A. S., Speaker K. J., Lindsay S. F., Uyenishi J., Reed J. M., et al. (2008). Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am. J. Physiol. Endocrinol. Metab. 294 E918–E927. 10.1152/ajpendo.00798.2007 [DOI] [PubMed] [Google Scholar]
  4. Almeida G. J., Khoja S. S., Piva S. R. (2018). Dose-response relationship between neuromuscular electrical stimulation and muscle function in patients with rheumatoid arthritis. Arthritis Rheumatol. 70:10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Atherton P. J., Babraj J., Smith K., Singh J., Rennie M. J., Wackerhage H. (2005). Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J. 19 786–788. 10.1096/fj.04-2179fje [DOI] [PubMed] [Google Scholar]
  6. Azman M. F., Azman A. W. (2017). The effect of electrical stimulation in improving muscle tone (Clinical). IOP Conf. Ser. 260:012020 10.1088/1757-899x/260/1/012020 [DOI] [Google Scholar]
  7. Bergfors M., Barnekow-Bergkvist M., Kalezic N., Lyskov E., Eriksson J. W. (2005). Short-term effects of repetitive arm work and dynamic exercise on glucose metabolism and insulin sensitivity. Acta Physiol. Scand. 183 345–356. 10.1111/j.1365-201x.2005.01407.x [DOI] [PubMed] [Google Scholar]
  8. Bloch S. A. A., Syburrah T., Rosendahl U., Kemp P. R., Griffiths M. J. D., Polkey M. I. (2014). A paradoxical rise in rectus femoris myotatin (GDF-8) and GDF-15 in response to neuromuscular electrical stimulation in critical care. Thorax 69 (Suppl. 2):A74. [Google Scholar]
  9. Caggiano E., Emrey T., Shirley S., Craik R. L. (1994). Effects of electrical stimulation or voluntary contraction for strengthening the quadriceps femoris muscles in an aged male population. J. Orthop. Sports Phys. Ther. 20 22–28. 10.2519/jospt.1994.20.1.22 [DOI] [PubMed] [Google Scholar]
  10. Carson B. P. (2017). The potential role of contraction-induced Myokines in the regulation of metabolic function for the prevention and treatment of type 2 diabetes. Front. Endocrinol. 8:97. 10.3389/fendo.2017.00097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Catoire M., Mensink M., Kalkhoven E., Schrauwen P., Kersten S. (2014). Identification of human exercise-induced myokines using secretome analysis. Physiol. Genomics 46 256–267. 10.1152/physiolgenomics.00174.2013 [DOI] [PubMed] [Google Scholar]
  12. Covington J. D., Tam C. S., Bajpeyi S., Galgani J. E., Noland R. C., Smith S. R., et al. (2016). Myokine expression in muscle and myotubes in response to exercise stimulation. Med. Sci. Sports Exerc. 48 384–390. 10.1249/MSS.0000000000000787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Crameri R. M., Aagaard P., Qvortrup K., Langberg H., Olesen J., Kjaer M. (2007). Myofibre damage in human skeletal muscle: effects of electrical stimulation versus voluntary contraction. J. Physiol. 583 365–380. 10.1113/jphysiol.2007.128827 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dalise S., Cavalli L., Ghuman H., Wahlberg B., Gerwig M., Chisari C., et al. (2017). Biological effects of dosing aerobic exercise and neuromuscular electrical stimulation in rats. Sci. Rep. 7:10830. 10.1038/s41598-017-11260-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Deley G., Eicher J. C., Verges B., Wolf J. E., Casillas J. M. (2008). Do low-frequency electrical myostimulation and aerobic training similarly improve performance in chronic heart failure patients with different exercise capacities? J. Rehabil. Med. 40 219–224. 10.2340/16501977-0153 [DOI] [PubMed] [Google Scholar]
  16. Dirks M. L., Wall B. T., Snijders T., Ottenbros C. L., Verdijk L. B., Van Loon L. J. (2014). Neuromuscular electrical stimulation prevents muscle disuse atrophy during leg immobilization in humans. Acta Physiol. 210 628–641. 10.1111/apha.12200 [DOI] [PubMed] [Google Scholar]
  17. Eriksson E., Haggmark T. (1979). Comparison of isometric muscle training and electrical stimulation supplementing isometric muscle training in the recovery after major knee ligament surgery. A preliminary report. Am. J. Sports Med. 7 169–171. 10.1177/036354657900700305 [DOI] [PubMed] [Google Scholar]
  18. Feng B. O., Wu W., Wang H., Wang J., Huang D., Cheng L. (2016). Interaction between muscle and bone, and improving the effects of electrical muscle stimulation on amyotrophy and bone loss in a denervation rat model via sciatic neurectomy. Biomed. Rep. 4 589–594. 10.3892/br.2016.637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fischer C. P. (2006). Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc. Immunol. Rev. 12 6–33. [PubMed] [Google Scholar]
  20. Fischer C. P., Hiscock N. J., Penkowa M., Basu S., Vessby B., Kallner A., et al. (2004). Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle. J. Physiol. 558 633–645. 10.1113/jphysiol.2004.066779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fluck M., Mund S. I., Schittny J. C., Klossner S., Durieux A. C., Giraud M. N. (2008). Mechano-regulated tenascin-C orchestrates muscle repair. Proc. Natl. Acad. Sci. U.S.A. 105 13662–13667. 10.1073/pnas.0805365105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Garneau L., Aguer C. (2019). Role of myokines in the development of skeletal muscle insulin resistance and related metabolic defects in type 2 diabetes. Diabetes Metab. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  23. Gondin J., Brocca L., Bellinzona E., D’antona G., Maffiuletti N. A., Miotti D., et al. (2011a). Neuromuscular electrical stimulation training induces atypical adaptations of the human skeletal muscle phenotype: a functional and proteomic analysis. J. Appl. Physiol. 110 433–450. 10.1152/japplphysiol.00914.2010 [DOI] [PubMed] [Google Scholar]
  24. Gondin J., Cozzone P. J., Bendahan D. (2011b). Is high-frequency neuromuscular electrical stimulation a suitable tool for muscle performance improvement in both healthy humans and athletes? Eur. J. Appl. Physiol. 111 2473–2487. 10.1007/s00421-011-2101-2 [DOI] [PubMed] [Google Scholar]
  25. Greiwe J. S., Cheng B., Rubin D. C., Yarasheski K. E., Semenkovich C. F. (2001). Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J. 15 475–482. 10.1096/fj.00-0274com [DOI] [PubMed] [Google Scholar]
  26. Guarascio P., Lusi E. A., Soccorsi F. (2004). Electronic muscular stimulators: a novel unsuspected cause of rhabdomyolysis. Br. J. Sports Med. 38:505. 10.1136/bjsm.2003.008540 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hartsell H. D. (1986). Electrical muscle stimulation and isometric exercise effects on selected quadriceps parameters. J. Orthop. Sports Phys. Ther. 8 203–209. 10.2519/jospt.1986.8.4.203 [DOI] [PubMed] [Google Scholar]
  28. Hawley J. A., Hargreaves M., Joyner M. J., Zierath J. R. (2014). Integrative biology of exercise. Cell 159 738–749. [DOI] [PubMed] [Google Scholar]
  29. He Z., Tian Y., Valenzuela P. L., Huang C., Zhao J., Hong P., et al. (2018). Myokine response to high-intensity interval vs. resistance exercise: an individual approach. Front. Physiol. 9:1735 10.3389/fphys.2018.01735 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hirose L., Nosaka K., Newton M., Laveder A., Kano M., Peake J., et al. (2004). Changes in inflammatory mediators following eccentric exercise of the elbow flexors. Exerc. Immunol. Rev. 10 75–90. [PubMed] [Google Scholar]
  31. Hody S., Croisier J. L., Bury T., Rogister B., Leprince P. (2019). Eccentric muscle contractions: risks and benefits. Front. Physiol. 10:536. 10.3389/fphys.2019.00536 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hoffmann C., Weigert C. (2017). Skeletal muscle as an endocrine organ: the role of Myokines in exercise adaptations. Cold Spring Harb. Perspect. Med. 7:a029793. 10.1101/cshperspect.a029793 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hsu M. J., Wei S. H., Chang Y. J. (2011). Effect of neuromuscular electrical muscle stimulation on energy expenditure in healthy adults. Sensors 11 1932–1942. 10.3390/s110201932 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Huang T., Larsen K. T., Ried-Larsen M., Moller N. C., Andersen L. B. (2014). The effects of physical activity and exercise on brain-derived neurotrophic factor in healthy humans: a review. Scand. J. Med. Sci. Sports 24 1–10. 10.1111/sms.12069 [DOI] [PubMed] [Google Scholar]
  35. Johannsen A. D., Krogh T. P. (2019). Rhabdomyolysis in an elite dancer after training with electromyostimulation: a case report. Transl. Sports Med. 2 294–297. 10.1002/tsm2.91 [DOI] [Google Scholar]
  36. Jones S., Man W. D., Gao W., Higginson I. J., Wilcock A., Maddocks M. (2016). Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst. Rev. 10:CD009419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Karavidas A. I., Raisakis K. G., Parissis J. T., Tsekoura D. K., Adamopoulos S., Korres D. A., et al. (2006). Functional electrical stimulation improves endothelial function and reduces peripheral immune responses in patients with chronic heart failure. Eur. J. Cardiovasc. Prev. Rehabil. 13 592–597. 10.1097/01.hjr.0000219111.02544.ff [DOI] [PubMed] [Google Scholar]
  38. Kastner A., Braun M., Meyer T. (2015). Two cases of Rhabdomyolysis after training with electromyostimulation by 2 young male professional soccer players. Clin. J. Sport Med. 25:e71-73. 10.1097/JSM.0000000000000153 [DOI] [PubMed] [Google Scholar]
  39. Kido K., Ato S., Yokokawa T., Makanae Y., Sato K., Fujita S. (2016). Acute resistance exercise-induced IGF1 expression and subsequent GLUT4 translocation. Physiol. Rep. 4:12907. 10.14814/phy2.12907 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kimura T., Kaneko F., Iwamoto E., Saitoh S., Yamada T. (2019). Neuromuscular electrical stimulation increases serum brain-derived neurotrophic factor in humans. Exp. Brain Res. 237 47–56. 10.1007/s00221-018-5396-y [DOI] [PubMed] [Google Scholar]
  41. Knaepen K., Goekint M., Heyman E. M., Meeusen R. (2010). Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Med. 40 765–801. 10.2165/11534530-000000000-00000 [DOI] [PubMed] [Google Scholar]
  42. Leal L. G., Lopes M. A., Batista M. L., Jr. (2018). Physical exercise-induced Myokines and muscle-Adipose tissue crosstalk: a review of current knowledge and the implications for health and Metabolic diseases. Front. Physiol. 9:1307. 10.3389/fphys.2018.01307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Lee J. H., Jun H. S. (2019). Role of Myokines in regulating skeletal muscle mass and function. Front. Physiol. 10:42 10.3389/fphys.2019.00042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Lightfoot A. P., Cooper R. G. (2016). The role of myokines in muscle health and disease. Curr. Opin. Rheumatol. 28 661–666. 10.1097/bor.0000000000000337 [DOI] [PubMed] [Google Scholar]
  45. Maekawa T., Ogasawara R., Tsutaki A., Lee K., Nakada S., Nakazato K., et al. (2018). Electrically evoked local muscle contractions cause an increase in hippocampal BDNF. Appl. Physiol. Nutr. Metab. 43 491–496. 10.1139/apnm-2017-0536 [DOI] [PubMed] [Google Scholar]
  46. Maffiuletti N. A., Gondin J., Place N., Stevens-Lapsley J., Vivodtzev I., Minetto M. A. (2018). Clinical use of neuromuscular electrical stimulation for neuromuscular rehabilitation: what are we overlooking? Arch. Phys. Med. Rehabil. 99 806–812. 10.1016/j.apmr.2017.10.028 [DOI] [PubMed] [Google Scholar]
  47. Marmon A. R., Snyder-Mackler L. (2011). Quantifying neuromuscular electrical stimulation dosage after knee arthroplasty. J. Life Sci. 5 581–583. [PMC free article] [PubMed] [Google Scholar]
  48. McPherron A. C., Lee S. J. (1997). Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. U.S.A. 94 12457–12461. 10.1073/pnas.94.23.12457 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Miyamoto T., Iwakura T., Matsuoka N., Iwamoto M., Takenaka M., Akamatsu Y., et al. (2018). Impact of prolonged neuromuscular electrical stimulation on metabolic profile and cognition-related blood parameters in type 2 diabetes: a randomized controlled cross-over trial. Diabetes Res. Clin. Pract. 142 37–45. 10.1016/j.diabres.2018.05.032 [DOI] [PubMed] [Google Scholar]
  50. Mosher D. S., Quignon P., Bustamante C. D., Sutter N. B., Mellersh C. S., Parker H. G., et al. (2007). A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet. 3:e79. 10.1371/journal.pgen.0030079.eor [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Nielsen A. R., Pedersen B. K. (2007). The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl. Physiol. Nutr. Metab. 32 833–839. 10.1139/h07-054 [DOI] [PubMed] [Google Scholar]
  52. Nosaka K., Aldayel A., Jubeau M., Chen T. C. (2011). Muscle damage induced by electrical stimulation. Eur. J. Appl. Physiol. 111 2427–2437. 10.1007/s00421-011-2086-x [DOI] [PubMed] [Google Scholar]
  53. Nosaka K., Clarkson P. M. (1996). Changes in indicators of inflammation after eccentric exercise of the elbow flexors. Med. Sci. Sports Exerc. 28 953–961. 10.1097/00005768-199608000-00003 [DOI] [PubMed] [Google Scholar]
  54. Nuhr M. J., Pette D., Berger R., Quittan M., Crevenna R., Huelsman M., et al. (2004). Beneficial effects of chronic low-frequency stimulation of thigh muscles in patients with advanced chronic heart failure. Eur. Heart J. 25 136–143. 10.1016/j.ehj.2003.09.027 [DOI] [PubMed] [Google Scholar]
  55. Ostrowski K., Schjerling P., Pedersen B. K. (2000). Physical activity and plasma interleukin-6 in humans–effect of intensity of exercise. Eur. J. Appl. Physiol. 83 512–515. 10.1007/s004210000312 [DOI] [PubMed] [Google Scholar]
  56. Paillard T., Noe F., Passelergue P., Dupui P. (2005). Electrical stimulation superimposed onto voluntary muscular contraction. Sports Med. 35 951–966. 10.2165/00007256-200535110-00003 [DOI] [PubMed] [Google Scholar]
  57. Pareja-Galeano H., Garatachea N., Lucia A. (2015). Exercise as a Polypill for Chronic diseases. Prog. Mol. Biol. Transl. Sci. 135 497–526. 10.1016/bs.pmbts.2015.07.019 [DOI] [PubMed] [Google Scholar]
  58. Pedersen B. K. (2013). Muscle as a secretory organ. Compr. Physiol. 3 1337–1362. 10.1002/cphy.c120033 [DOI] [PubMed] [Google Scholar]
  59. Pedersen B. K., Akerstrom T. C., Nielsen A. R., Fischer C. P. (2007). Role of myokines in exercise and metabolism. J. Appl. Physiol. 103 1093–1098. [DOI] [PubMed] [Google Scholar]
  60. Pedersen B. K., Febbraio M. A. (2008). Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88 1379–1406. 10.1152/physrev.90100.2007 [DOI] [PubMed] [Google Scholar]
  61. Pedersen B. K., Febbraio M. A. (2012). Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8 457–465. 10.1038/nrendo.2012.49 [DOI] [PubMed] [Google Scholar]
  62. Pedersen B. K., Fischer C. P. (2007). Beneficial health effects of exercise–the role of IL-6 as a myokine. Trends Pharmacol. Sci. 28 152–156. [DOI] [PubMed] [Google Scholar]
  63. Pedersen B. K., Steensberg A., Fischer C., Keller C., Keller P., Plomgaard P., et al. (2003). Searching for the exercise factor: is IL-6 a candidate? J. Muscle Res. Cell Motil. 24 113–119. [DOI] [PubMed] [Google Scholar]
  64. Pellegrino M. A., Desaphy J. F., Brocca L., Pierno S., Camerino D. C., Bottinelli R. (2011). Redox homeostasis, oxidative stress and disuse muscle atrophy. J. Physiol. 589 2147–2160. 10.1113/jphysiol.2010.203232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Piccirillo R. (2019). Exercise-induced Myokines with therapeutic potential for muscle wasting. Front. Physiol. 10:287. 10.3389/fphys.2019.00287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Rodriguez J., Vernus B., Toubiana M., Jublanc E., Tintignac L., Leibovitch S., et al. (2011). Myostatin inactivation increases myotube size through regulation of translational initiation machinery. J. Cell Biochem. 112 3531–3542. 10.1002/jcb.23280 [DOI] [PubMed] [Google Scholar]
  67. Sanchis-Gomar F., Pareja-Galeano H., Mayero S., Perez-Quilis C., Lucia A. (2014). New molecular targets and lifestyle interventions to delay aging sarcopenia. Front. Aging Neurosci. 6:156 10.3389/fnagi.2014.00156 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Sanchis-Gomar F., Perez-Quilis C. (2014). The p38-PGC-1alpha-irisin-betatrophin axis: exploring new pathways in insulin resistance. Adipocyte 3 67–68. 10.4161/adip.27370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Sbruzzi G., Ribeiro R. A., Schaan B. D., Signori L. U., Silva A. M., Irigoyen M. C., et al. (2010). Functional electrical stimulation in the treatment of patients with chronic heart failure: a meta-analysis of randomized controlled trials. Eur. J. Cardiovasc. Prev. Rehabil. 17 254–260. [DOI] [PubMed] [Google Scholar]
  70. Scheler M., Irmler M., Lehr S., Hartwig S., Staiger H., Al-Hasani H., et al. (2013). Cytokine response of primary human myotubes in an in vitro exercise model. Am. J. Physiol. Cell Physiol. 305 C877–C886. 10.1152/ajpcell.00043.2013 [DOI] [PubMed] [Google Scholar]
  71. Schnyder S., Handschin C. (2015). Skeletal muscle as an endocrine organ: PGC-1alpha, myokines and exercise. Bone 80 115–125. 10.1016/j.bone.2015.02.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Schuelke M., Wagner K. R., Stolz L. E., Hubner C., Riebel T., Komen W., et al. (2004). Myostatin mutation associated with gross muscle hypertrophy in a child. N. Engl. J. Med. 350 2682–2688. [DOI] [PubMed] [Google Scholar]
  73. Snyder-Mackler L., Delitto A., Stralka S. W., Bailey S. L. (1994). Use of electrical stimulation to enhance recovery of quadriceps femoris muscle force production in patients following anterior cruciate ligament reconstruction. Phys. Ther. 74 901–907. [DOI] [PubMed] [Google Scholar]
  74. Snyder-Mackler L., Ladin Z., Schepsis A. A., Young J. C. (1991). Electrical stimulation of the thigh muscles after reconstruction of the anterior cruciate ligament. Effects of electrically elicited contraction of the quadriceps femoris and hamstring muscles on gait and on strength of the thigh muscles. J. Bone Joint Surg. Am. 73 1025–1036. [PubMed] [Google Scholar]
  75. So B., Kim H. J., Kim J., Song W. (2014). Exercise-induced myokines in health and metabolic diseases. Integr. Med. Res. 3 172–179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Steensberg A., Fischer C. P., Keller C., Moller K., Pedersen B. K. (2003). IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am. J. Physiol. Endocrinol. Metab. 285 E433–E437. [DOI] [PubMed] [Google Scholar]
  77. Steensberg A., Keller C., Starkie R. L., Osada T., Febbraio M. A., Pedersen B. K. (2002). IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 283 E1272–E1278. [DOI] [PubMed] [Google Scholar]
  78. Steensberg A., Van Hall G., Osada T., Sacchetti M., Saltin B., Klarlund Pedersen B. (2000). Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 529(Pt 1), 237–242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Truong A. D., Kho M. E., Brower R. G., Feldman D. R., Colantuoni E., Needham D. M. (2017). Effects of neuromuscular electrical stimulation on cytokines in peripheral blood for healthy participants: a prospective, single-blinded Study. Clin. Physiol. Funct. Imaging 37 255–262. 10.1111/cpf.12290 [DOI] [PubMed] [Google Scholar]
  80. Veldman M. P., Gondin J., Place N., Maffiuletti N. A. (2016). Effects of neuromuscular electrical stimulation training on endurance performance. Front. Physiol. 7:544 10.3389/fphys.2016.00544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Wahl P., Hein M., Achtzehn S., Bloch W., Mester J. (2014). Acute metabolic, hormonal and psychological responses to cycling with superimposed electromyostimulation. Eur. J. Appl. Physiol. 114 2331–2339. 10.1007/s00421-014-2952-4 [DOI] [PubMed] [Google Scholar]
  82. Wahl P., Hein M., Achtzehn S., Bloch W., Mester J. (2015). Acute effects of superimposed electromyostimulation during cycling on myokines and markers of muscle damage. J. Musculoskelet. Neuronal. Interact. 15 53–59. [PMC free article] [PubMed] [Google Scholar]
  83. Wall B. T., Dirks M. L., Verdijk L. B., Snijders T., Hansen D., Vranckx P., et al. (2012). Neuromuscular electrical stimulation increases muscle protein synthesis in elderly type 2 diabetic men. Am. J. Physiol. Endocrinol. Metab. 303 E614–E623. 10.1152/ajpendo.00138.2012 [DOI] [PubMed] [Google Scholar]
  84. Wall B. T., Morton J. P., Van Loon L. J. (2015). Strategies to maintain skeletal muscle mass in the injured athlete: nutritional considerations and exercise mimetics. Eur. J. Sport Sci. 15 53–62. 10.1080/17461391.2014.936326 [DOI] [PubMed] [Google Scholar]
  85. Whitham M., Parker B. L., Friedrichsen M., Hingst J. R., Hjorth M., Hughes W. E., et al. (2018). Extracellular vesicles provide a means for tissue crosstalk during exercise. Cell Metab. 27:e234. 10.1016/j.cmet.2017.12.001 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Physiology are provided here courtesy of Frontiers Media SA

RESOURCES